Literature DB >> 25964732

MMR Vaccine: When Is the Right Time for the Second Dose?

Oscar R Herrera1, Terrika A Thornton2, Richard A Helms3, Stephan L Foster2.   

Abstract

Outbreaks of measles have been reported over the past 5 years, particularly affecting children between the ages of 1 and 5 years. Most of these children are younger than the age recommended by the Advisory Committee on Immunization Practices for the second dose of measles-mumps-rubella (MMR) vaccine. Question may arise as to whether strict adherence to the scheduled second dose is required or whether there is opportunity for earlier immunization under special circumstances (e.g., traveling abroad, poor response as evidenced by titer levels). The history of measles, its characteristics, and its evolving past and current immunization policies will be reviewed, focusing on the original intent of the recommended schedule and presenting a case in which deviating from current practice could be justified.

Entities:  

Keywords:  immunization; measles-mumps-rubella vaccine; vaccination

Year:  2015        PMID: 25964732      PMCID: PMC4418682          DOI: 10.5863/1551-6776-20.2.144

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  21 in total

1.  STUDIES ON IMMUNITY TO MEASLES.

Authors:  S KRUGMAN; J P GILES; H FRIEDMAN; S STONE
Journal:  J Pediatr       Date:  1965-03       Impact factor: 4.406

2.  Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.

Authors:  P Albrecht; F A Ennis; E J Saltzman; S Krugman
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

3.  Maternally derived measles immunity in children of naturally infected and vaccinated mothers.

Authors:  P J Jenks; E O Caul; A P Roome
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

4.  Measles outbreak in a fully immunized secondary-school population.

Authors:  T L Gustafson; A W Lievens; P A Brunell; R G Moellenberg; C M Buttery; L M Sehulster
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

5.  Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures.

Authors:  B M Nkowane; S W Bart; W A Orenstein; M Baltier
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

6.  Measles immunization. Successes and failures.

Authors:  A S Yeager; J H Davis; L A Ross; B Harvey
Journal:  JAMA       Date:  1977-01-24       Impact factor: 56.272

7.  Persistence of measles antibody after revaccination.

Authors:  L E Markowitz; P Albrecht; W A Orenstein; S M Lett; T J Pugliese; D Farrell
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

8.  Immune response with particular reference to the use of multiple antigens.

Authors:  P F Wehrle
Journal:  Calif Med       Date:  1968-12

Review 9.  Appropriate age for measles vaccination in the United States.

Authors:  W A Orenstein; L Markowitz; S R Preblud; A R Hinman; A Tomasi; K J Bart
Journal:  Dev Biol Stand       Date:  1986

10.  Maternally derived measles immunity in era of vaccine-protected mothers.

Authors:  J L Lennon; F L Black
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

View more
  1 in total

1.  Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.

Authors:  Aleksandra Patić; Mirjana Štrbac; Vladimir Petrović; Vesna Milošević; Mioljub Ristić; Ivana Hrnjaković Cvjetković; Snežana Medić
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.